NDC 17856-0045-06 - MAX relief junior
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0045
- Requested NDC
- 17856-0045-06
- Package NDCs from labels
- 17856-0045-5, 17856-0045-1, 17856-0045-6, 17856-0045-2, 17856-0045-7, 17856-0045-3, 17856-0045-8, 17856-0045-4, 17856-0045-06
- Manufacturer
- ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS
- Effective date
- 2025-12-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MAX relief junior - ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | 2025-12-10 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0045-1 | MAX relief junior | 48 in 1 BOX, UNIT-DOSE | LIQUID | 48 | 2 | |
| 17856-0045-2 | MAX relief junior | 120 in 1 BOX, UNIT-DOSE | LIQUID | 120 | 2 | |
| 17856-0045-3 | MAX relief junior | 120 in 1 BOX, UNIT-DOSE | LIQUID | 120 | 2 | |
| 17856-0045-4 | MAX relief junior | 120 in 1 BOX, UNIT-DOSE | LIQUID | 120 | 2 | |
| 17856-0045-5 | MAX relief junior | 7.5 mL in 1 SYRINGE | LIQUID | 7.5 | 2 | |
| 17856-0045-6 | MAX relief junior | 1.25 mL in 1 SYRINGE | LIQUID | 1.25 | 2 | |
| 17856-0045-7 | MAX relief junior | 2.5 mL in 1 SYRINGE | LIQUID | 2.5 | 2 | |
| 17856-0045-8 | MAX relief junior | 2.5 mL in 1 SYRINGE | LIQUID | 2.5 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0045 | MAX RELIEF JUNIOR (ACETAMINOPHEN) LIQUID [ATLANTIC BIOLOGICALS CORP.] | 1 | Current NDC, 8 package rows | 20240229_ff1f6f82-0c7c-4e3f-a2bd-3185e16fa770.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | WinCo Foods, LLC | fbd2a03f-c9cd-4b0d-b9b1-aaa3bc14efb4 | 2026-10-13 | Warnings | M013 362O9ITL9D |
| Adult Low Dose Enteric Coated Aspirin | ASPIRIN | REMEDYREPACK INC. | 3d89849f-60a1-40fc-bd0a-a5ff9f758a49 | 2026-10-13 | Warnings | M013 |
| Maximum Strength Mucinex Fast-Max Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | Reckitt Benckiser LLC | 182222b5-a852-4dbe-b05f-a41d89806021 | 2026-10-13 | Warnings | 362O9ITL9D |
| Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | Walgreen Company | b6d9f421-b236-4660-be7f-85a878f2fc61 | 2026-10-09 | Warnings | 362O9ITL9D |
| Vicks DayQuil Intense Flu Rapid Release LiquiCaps | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE | The Procter & Gamble Manufacturing Company | 4cd4213c-7569-32da-e063-6294a90a5695 | 2026-10-09 | Warnings | 362O9ITL9D |
| Vicks NyQuil Intense Flu Rapid Release LiquiCaps | ACETAMINOPHEN, DOXYLAMINE SUCCINATE, DEXTROMETHORPHAN HBR | The Procter & Gamble Manufacturing Company | 354906d1-455b-460c-8283-984e73c09d7e | 2026-10-09 | Warnings | 362O9ITL9D |
| Vicks NyQuil SINUS PAIN and HEADACHE | ACETAMINOPHEN, DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 4c4ca296-ea6c-1f19-e063-6294a90a8161 | 2026-10-09 | Warnings | 362O9ITL9D |
| Vicks Formula 44 DM Painful Cough and Sore Throat | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | The Procter & Gamble Manufacturing Company | d536f159-304f-4759-be14-0e4895777c97 | 2026-10-09 | Warnings | 362O9ITL9D |
| Vicks Sinex Severe PAIN, MUCUS and CHEST CONGESTION | ACETAMINOPHEN, GUAIFENESIN | The Procter & Gamble Manufacturing Company | 5605aab6-6074-0a3b-e063-6294a90a49a2 | 2026-10-09 | Warnings | 362O9ITL9D |
| infants pain fever | ACETAMINOPHEN | H E B | 1da89528-f658-4103-8041-cee4c775d73f | 2026-10-09 | Warnings | M013 307668 362O9ITL9D |
| Topcare Migraine Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Topco Associates LLC | a2a9fbec-639f-4002-aa34-51b4563fc38e | 2026-10-09 | Warnings | 362O9ITL9D |
| aspirin | ASPIRIN | Meijer Distribution Inc | 338aea3b-a38f-424f-9006-3ede3825bf90 | 2026-10-09 | Warnings | M013 |
| infants pain fever | ACETAMINOPHEN | H E B | ab8ecc76-9621-4acc-b59b-fcf6cb2e52ef | 2026-10-09 | Warnings | M013 307668 362O9ITL9D |
| Complete Cold Relief | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Belmora LLC | a81fc021-9a9f-4cec-a1a6-73e3f983b78d | 2026-10-08 | Warnings | 362O9ITL9D |
| butalbital and acetaminophen | BUTALBITAL AND ACETAMINOPHEN | Granules Pharmaceuticals Inc. | 2091c292-b77b-4ce6-8bba-436c74eee3d7 | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Acetaminophen and Ibuprofen | ACETAMINOPHEN AND IBUPROFEN | Granules Pharmaceuticals Inc. | 0f8b9524-8fe3-47cf-bacd-93047442d90d | 2026-10-08 | Warnings | 362O9ITL9D |
| ACETAMINOPHEN | ACETAMINOPHEN | Granules Pharmaceuticals Inc. | d5352861-6926-f1b0-e053-2a95a90a7d66 | 2026-10-08 | Warnings | 362O9ITL9D |
| ACETAMINOPHEN | ACETAMINOPHEN | Granules Pharmaceuticals Inc. | d5d49146-665e-4a93-e053-2995a90aca59 | 2026-10-08 | Warnings | M013 362O9ITL9D |
| Acetaminophen and Ibuprofen Back Pain | ACETAMINOPHEN AND IBUPROFEN | Granules Pharmaceuticals Inc. | 32562aa1-f44b-649e-e063-6394a90a47c8 | 2026-10-08 | Warnings | 362O9ITL9D |
| Oxycodone and Acetaminophen | OXYCODONE AND ACETAMINOPHEN | Granules Pharmaceuticals Inc. | cc966d57-7cdc-4de3-bbcf-718e2fce9cb7 | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.